In this issue of JAMA Cardiology, Lytzen et al1 report the findings of their study on prenatal screening (PNS) for congenital heart disease (CHD) in Denmark.1 Notably, they find that with increased training and experience, technicians were able to identify roughly 70% of cases of major CHD in fetuses. Their findings are remarkable; however, the data also raise broader concerns.
Kon AA. Ethical Implications of Prenatal Screening for Congenital Heart Disease. JAMA Cardiol. 2018;3(9):837–838. doi:10.1001/jamacardio.2018.1944
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.